Studying the Role of P-glycoprotein in Resistance to Tamoxifen in Humen Breast Cancer T47D Cells by Immunocytochemistry
- 15 March 2005
- journal article
- Published by Science Alert in International Journal of Pharmacology
- Vol. 1 (2), 112-117
- https://doi.org/10.3923/ijp.2005.112.117
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Switching Trial of Adjuvant Tamoxifen with an Aromatase Inhibitor in Postmenopausal Patients with Breast CancerClinical Breast Cancer, 2004
- Overcoming Endocrine Therapy Resistance by Signal Transduction InhibitionThe Oncologist, 2004
- Tamoxifen Resistance in Breast CancerDrugs, 2001
- Chemoprevention of breast cancerBreast Cancer Research and Treatment, 2000
- Reversal of multidrug resistance by novel verapamil analogs in cancer cellsAnti-Cancer Drugs, 1998
- Co-operative, competitive and non-competitive interactions between modulators of P-glycoproteinBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1996
- Interaction of tamoxifen with the multidrug resistance P-glycoproteinBritish Journal of Cancer, 1995
- Effect of tamoxifen on mitoxantrone cytotoxicity in drug-sensitive and multidrug-resistant MCF-7 cellsCancer Chemotherapy and Pharmacology, 1995
- P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapyBritish Journal of Cancer, 1992
- Selection and Characterization of a Breast Cancer Cell Line Resistant to the Antiestrogen LY 117018Endocrinology, 1985